The Army’s Quick Cure
Research for a Covid-19 drug by Airlangga University sparked a polemic. Aside from its effectiveness, its adherence to clinical trials protocol is also questioned. The ball is now in the Indonesia Food and Drug Authority’s court.
Edition : Monday, August 24, 2020
Army Chief of Staff Gen. Andika Perkasa receives the phase III clinical test results of Covid-19 drug from Airlangga University Rector Mohammad Nasih in Jakarta,
August 15. ANTARA/Aditya Pradana Putra
THE Rector of Airlangga University (Unair), Mohammad Nasih, hurried to the E Building in the Indonesian Army Headquarters in Jalan Veteran, Central Jakarta, on Saturday, August 15. He was there to deliver the phase III clinical trial result of a Covid-19 drug to the Army—which is sponsoring the research, alongside the State Intelligence Agency (BIN). “Of course, since this will be a new drug, it is expected to be the first Covid-19 cu
...W251bGwsIjIwMjEtMDctMjggMTQ6NDQ6MTQiXQ